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Summary
The 2L21 peptide, which confers protection to dogs against challenge with virulent canine
parvovirus (CPV), was expressed in tobacco chloroplasts as a C-terminal translational fusion
with the cholera toxin B subunit (CTB) or the green fluorescent protein (GFP). Expression of
recombinant proteins was dependent on plant age. A very high-yield production was
achieved in mature plants at the time of full flowering (310 mg CTB-2L21 protein per plant).
Both young and senescent plants accumulated lower amounts of recombinant proteins
than mature plants. This shows the importance of the time of harvest when scaling up the
process. The maximum level of CTB-2L21 was 7.49 mg/g fresh weight (equivalent to 31.1%
of total soluble protein, TSP) and that of GFP-2L21 was 5.96 mg/g fresh weight (equivalent
to 22.6% of TSP). The 2L21 inserted epitope could be detected with a CPV-neutralizing
monoclonal antibody, indicating that the epitope is correctly presented at the C-terminus
of the fusion proteins. The resulting chimera CTB-2L21 protein retained pentamerization
and GM1-ganglioside binding characteristics of the native CTB and induced antibodies able
to recognize VP2 protein from CPV. To our knowledge, this is the first report of an animal
vaccine epitope expression in transgenic chloroplasts. The high expression of antigens in
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chloroplasts would reduce the amount of plant material required for vaccination (∼100 mg

fusion protein, GFP, peptide vaccine,

for a dose of 500 µg antigen) and would permit encapsulation of freeze-dried material or

plastid transformation.

pill formation.

Introduction
Traditional vaccines use either killed or attenuated whole
disease-causing organisms. The advances in molecular biology
have enabled the identification of antigens capable of
eliciting a protective immune response. Antigen production in
a heterologous expression system allows the development
of subunit vaccines, improving aspects such as safety and
processing (Walmsley and Arntzen, 2000). The production of
recombinant vaccine proteins in microorganisms is expensive
and requires stringent purification protocols. The alternative
production in plants could circumvent these problems for
a number of reasons: (i) the culture of plants in the field is
straightforward, fairly cheap and can be scaled up with a
low cost in relation to fermentation processes (10 –50 times
© 2004 Blackwell Publishing Ltd

cheaper) (Kusnadi et al., 1997); (ii) the health risks arising
from contamination with human pathogens or toxins are
minimized; (iii) the plant material can be used directly as food
or feed, avoiding purification and generating an oral vaccine;
(iv) plant-based vaccines for oral delivery may be particularly
useful for inducing immunity to disease organisms that colonize mucosal surfaces. Other advantages of plant-produced
vaccines include heat stability, no need for injection-related
manipulations of animals or hazards in humans, and the
production of multicomponent combined vaccines.
It has been demonstrated that proteins produced in plants
are able to elicit immune responses against important human
or animal pathogens (Thanavala et al., 1995; Arakawa
et al., 1998a; Modelska et al., 1998; Tacket et al., 1998, 2000;
Castanon et al., 1999; Wigdorovitz et al., 1999; Streatfield
141
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et al., 2001). Indeed, the first plant oral vaccine against the
Norwalk virus is pending approval in the USA. Nevertheless,
one of the main problems related to vaccine production
in nuclear transgenic plants is the low expression level of foreign antigens. The average expression levels of recombinant
antigens in stably transformed plants are generally on the
level of 0.01–0.4% of the total soluble protein (TSP) (Daniell
et al., 2001c), making the immunization protocols very long
and economically non-viable. However, some recombinant
proteins reach exceptionally high expression levels by nuclear
transformation; for example, the Aspergillus niger phytase
accumulates to 14% TSP in tobacco leaves (Verwoerd et al.,
1995) and the heat-labile toxin of Escherichia coli has been
reported to reach 12% in maize seeds (Streatfield et al., 2003).
The quantity of plant tissue for an oral vaccine dose must
be of practical size for consumption, enabling pill processing.
Increasing the expression levels of recombinant proteins is
therefore a key step.
An alternative to improve foreign protein expression is
chloroplast transformation. Foreign genes integrated in
the tobacco chloroplast genome result in the accumulation of
exceptionally large quantities of recombinant proteins, up to
46% of TSP (De Cosa et al., 2001). Hyperexpression of the
transgenes in the chloroplast is attributed to the high copy
number of the foreign gene (up to 10 000 copies /cell) and
to the higher stability of the protein in the stroma of the
chloroplast in relation to the cytoplasm. Biopharmaceutical
compounds, such as human somatotropin (Staub et al., 2000),
human serum albumin (Fernández-San Millán et al., 2003),
antimicrobial peptides (DeGray et al., 2001), the B-subunit of
the cholera toxin (CTB) (Daniell et al., 2001a) and the tetanus
toxin (Tregoning et al., 2003), have been expressed at high
levels (4–25% of TSP), suggesting that high expression is
gene independent. Thus, chloroplast technology could be
a feasible and forthcoming strategy to improve oral vaccine
expression.
Additionally, chloroplast transformation has other advantages over nuclear transformation (Bogorad, 2000; Bock,
2001; Daniell et al., 2002). So far, gene silencing has not been
described in transgenic chloroplasts achieving high expression levels of recombinant proteins (De Cosa et al., 2001;
Tregoning et al., 2003). The environmental concern of transgene escape through pollen in nuclear transgenic plants is
overcome by chloroplast transformation due to the maternal
inheritance of plastids in most of the cultivated plants (Daniell,
2002). Recently, Huang et al. (2003) have described the
transfer of DNA from the chloroplast to the nuclear genome
at a frequency of 0.006%. Daniell and Parkinson (2003) have
pointed out some technical aspects of this article, deducing

that the simultaneous integration of transgenes into the
nuclear and chloroplast genomes occurred in the transgenic
lines analysed. Notwithstanding, both articles conclude that,
even if transgenes with plastid regulatory sequences are
transposed from chloroplast to nuclear genomes, they will
not be functional, eliminating concerns about such transfer.
Multigene engineering is feasible by chloroplast transformation in a single step because of the ability of chloroplasts to
process polycistrons (De Cosa et al., 2001; Daniell and Dhingra,
2002; Ruiz et al., 2003). This will be very useful to produce
multicomponent vaccines in transgenic chloroplasts.
In the present work, we have obtained high levels of a
peptide-based vaccine by chloroplast transformation of tobacco
plants. We selected a linear antigenic peptide (named 2L21)
from the VP2 capsid protein (amino acids 2–23) of the canine
parvovirus (CPV). This parvovirus infects young animals
producing haemorrhagic gastroenteritis and myocarditis. The
2L21 synthetic peptide chemically coupled to KLH carrier
protein has been extensively studied and has been shown to
effectively protect dogs and minks against parvovirus infection (Langeveld et al., 1994b, 1995). Previously, this peptide
has been successfully expressed in nuclear transgenic plants
as an N-terminal translational fusion of GUS protein (Gil et al.,
2001). Also, shorter peptides sharing sequence with the 2L21
epitope have been correctly expressed in plant viruses eliciting
CPV-neutralizing antibodies in mice (Fernandez-Fernandez
et al., 1998; Langeveld et al., 2001). We have expressed the
2L21 peptide fused either to CTB or the green fluorescent
protein (GFP). In this report, we demonstrate that the resulting
fusion proteins are efficiently expressed and accumulated
in chloroplast transgenic plants at higher levels (up to 10-fold)
than those previously reported in nuclear transformation (Gil
et al., 2001).

Results and discussion
Vector construction
Three chloroplast transformation vectors were designed
(Figure 1a). All included: (i) the trnI and trnA border sequences for homologous recombination in the inverted
repeat regions of the chloroplast genome; (ii) the chimeric
aminoglycoside 3′-adenylyltransferase (aadA) gene, conferring resistance to spectinomycin and streptomycin; and
(iii) the betaine aldehyde dehydrogenase (BADH ) gene, conferring resistance to betaine aldehyde. Both genes are driven
by the constitutive promoter of the rRNA operon (Prrn), each
with individual ribosome binding sites (GGAGG). The foreign
gene was inserted immediately downstream of the promoter
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141– 153
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and the 5′-untranslated region (UTR) of the psbA gene
(Figure 1a). In the pLD-2L21 vector, the foreign gene consisted of a 66 bp long DNA sequence encoding the 2L21
epitope of the CPV VP2 protein. The pLD-CTB-2L21 vector
included a gene fusion of the 2L21 sequence to the C-terminus
of the CTB, with the sequence of a flexible hinge tetrapeptide
(GPGP) in between. This tetrapeptide may reduce steric
hindrance between the CTB and the 2L21 peptide, facilitating

CTB subunit assembly. It has been successfully used to express CTB fused to insulin or NSP4 rotavirus in potato plants
(Arakawa et al., 1998b, 2001). The pLD-GFP-2L21 vector
included the gene encoding the soluble modified GFP protein
(Davis and Vierstra, 1998) instead of the CTB gene. We chose
CTB for the fusion protein because it is a potent mucosal
immunogen as a result of CTB binding to the intestinal
epithelial cells via GM1-ganglioside receptors, enhancing
the immune response when coupled to other antigens
(Holmgren et al., 1993; Mor et al., 1998). GFP was selected for
the fusion protein because the 14-amino acid N-terminal GFP
fusion to 5-enolpyruvylshikimate-3-phosphate synthase increased the protein accumulation in transgenic chloroplasts of
tobacco (Ye et al., 2001). In addition, GFP can be used as a
reporter gene and therefore facilitates the selection of
transgenic plants.
After bombardment, leaf fragments were cultured under
the selection of spectinomycin. Five weeks later, 4–5 shoots
appeared from each bombarded leaf. Previously described
protocols (Daniell, 1993, 1997) were followed to obtain
homoplasmic plants.

Determination of chloroplast integration and
homoplasmy
Integration of the foreign genes into the chloroplast genome
was confirmed by polymerase chain reaction (PCR) in the
shoots developed on spectinomycin-selective medium. The
strategy was based on one primer, landed on the chloroplast
genome upstream of the trnI gene used for homologous
recombination, and a second primer, landed on the aadA
gene (Figure 1a). The PCR product cannot be obtained in
nuclear transgenic plants, spontaneous mutants or nontransformed shoots. It was found that 100% of the shoots
analysed were PCR positive, whereas wild-type shoots did

Figure 1 Vector constructs and integration of transgenes into the
chloroplast genome. (a) Regions for homologous recombination are
underlined in the native chloroplast genome. The 2L21 sequence or
fusion sequences, GFP-2L21 and CTB-2L21, are driven by the psbA
promoter. Arrows within boxes show the direction of the transcription.
Numbers to the right indicate the predicted hybridizing fragments when
total DNA digested with EcoRI was probed with probe P1. (b) The 0.8 kb
fragment (P1) of the targeting region for homologous recombination and
the 108 bp 2L21 sequence (P2) were used as probes for the Southern blot
analysis. (c, d) Southern blot analysis of two independent lines (1, 2) for
each transformation cassette. Blots were probed with P1 (c) and P2 (d).
2L21, sequence included in the VP2 gene of the canine parvovirus; aadA,
aminoglycoside 3′-adenylyltransferase; BADH, betaine aldehyde
dehydrogenase; CTB, cholera toxin B; GFP, green fluorescent protein;
Prrn, 16S rRNA promoter; UTR, untranslated region; WT, wild-type Petit
Havana plant.
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141–153
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not amplify any fragment (data not shown). In order to obtain
homoplasmic plants, confirmed PCR transformants were
subjected to a second round of selection in a medium of the
same composition. Southern blot analysis was performed on
shoots developed under these conditions. The 0.8 kb probe,
homologous to the flanking regions trnI and trnA (Figure 1b),
was used to verify site-specific integration and to check
homoplasmy. Total plant DNA was digested with EcoRI. DNA
from non-transformed plants produced a 4.5 kb fragment
(Figures 1a,c). Transformed plants produced two fragments:
(i) a 2.1 kb fragment common to all of them; and (ii) 3.9 (pLD2L21), 5.2 (pLD-CTB-2L21) or 5.6 kb (pLD-GFP-2L21) fragments. To confirm that the 3.9, 5.2 and 5.6 kb fragments
contained the 2L21 sequence, the same blot was hybridized
with P2 probe (Figure 1b) homologous to the 2L21 sequence.
As expected, hybridization was observed only in the upper
bands of the chloroplast transgenic lines (Figure 1d). Southern
blot analysis of T1 generation confirmed that all six transgenic lines analysed maintained homoplasmy.
Plants transformed with pLD-GFP-2L21 vector showed
uniform green fluorescence after illumination with ultraviolet
light (data not shown). No chimeric plants were observed.

Immunoblot analysis of chloroplast-synthesized 2L21
epitope and fusion proteins
The detection of the recombinant proteins in transformed
chloroplasts was performed with the monoclonal antibody
(mAb) 3C9, specific for the 2L21 epitope. This antibody
has been used previously in the detection of the 2L21 epitope
expressed in different systems, such as baculovirus or Arabidopsis (Lopez de Turiso et al., 1992; Gil et al., 2001). There was
no cross-reaction between mAb 3C9 and wild-type tobacco
plant proteins (Figure 2a,b). Plants transformed with the
plasmid pLD-2L21 showed no detectable signal in the
Western blot (Figure 2a). To discard a putative problem of
detection limit or peptide diffusion in polyacrylamide gel electrophoresis (PAGE), a dot-blot was performed on three plants,
loading 50 µg per dot. No signal was detected, although a
clear spot appeared when synthetic 2L21 peptide was
used as positive control (data not shown). A clear band of
the expected GFP-2L21 protein size (29 kDa) was observed
in pLD-GFP-2L21-transformed plants (Figure 2a).
Chloroplast-synthesized CTB-2L21 protein developed with
mAb 3C9 (Figure 2b) or with anti-CTB serum (Figure 2c) as
the primary antibody appeared as aggregates in unboiled
samples from pLD-CTB-2L21-transformed plants. Unboiled
purified bacterial CTB developed with anti-CTB serum
(Figure 2c) also appeared as aggregates although, as expected,

Figure 2 Western blot analysis of 2L21 expression in transgenic
chloroplasts. Blots were detected using mouse anti-2L21 (a, b) or rabbit
anti-CTB (c) as primary antibody. (a) Two independent lines (1, 2) of 2L21
and GFP-2L21 chloroplast transgenic plants. (b, c) Two independent lines
(1, 2) of CTB-2L21 chloroplast transgenic plants. Five micrograms of plant
total protein were loaded per well, except for boiled samples in blot (c)
where 10 µg of protein were loaded. 2L21, epitope from the VP2 protein
of the canine parvovirus; Bact CTB, bacterial CTB; CTB, cholera toxin B;
GFP, green fluorescent protein; VP2, protein of the canine parvovirus that
includes the 2L21 epitope; WT, wild-type Petit Havana plant.

the molecular weights of these aggregates were lower
than those observed in chloroplast-derived CTB-2L21 protein.
Bacterial CTB antigen showed no cross-reaction with mAb
3C9 (Figure 2b). To clarify the nature of these aggregates,
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141– 153
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chloroplast-derived CTB-2L21 and bacterial CTB samples
were boiled for 5 min. After heat treatment, a prominent
band corresponding to the CTB monomer form (12 kDa) was
observed in bacterial CTB samples hybridized with anti-CTB
serum (Figure 2c). In the case of heat-treated chloroplastderived CTB-2L21 protein, differences were observed depending on the primary antibody used for hybridization. Prominent
bands corresponding to the expected size of the CTB-2L21
monomer (14 kDa) and dimer (28 kDa) were detected when
the blot was hybridized with mAb 3C9, although higher oligomers were also visualized (Figure 2b). However, in the blot
developed with anti-CTB serum, the CTB-2L21 monomer
was the most abundant form, although some dimers could
also be seen (Figure 2c). It must be noted that native CTB
is assembled in a pentameric structure by disulphide bridge
formation, with a molecular weight of 45 kDa. Bands above
45 kDa in the case of bacterial CTB, or 70 kDa in the case
of CTB-2L21, must reflect aggregates of CTB-2L21 or CTB
pentamers labile to heat treatment. Arakawa et al. (1998b)
expressed the CTB fused to insulin in potato tubers and
also observed the CTB-insulin oligomeric form and the corresponding monomeric form after heat treatment. We observed
a different sensitivity of the anti-CTB antibody against boiled
or unboiled plant samples. Very faint bands were observed in
boiled samples in relation to the unboiled ones, even though
a double amount of total protein was loaded (Figure 2c). This
fact was not observed with mAb 3C9. Unboiled purified
bacterial CTB appeared partially dissociated into dimers and
monomers on storage at 4 °C for several months. The same
behaviour was observed by Daniell et al. (2001a).

GM1-ganglioside enzyme-linked immunosorbent
binding assay
Chloroplast-synthesized CTB-2L21 protein showed a strong
affinity for GM1-ganglioside similar to that shown by purified
bacterial CTB (Figure 3). This result indicates that CTB-2L21
fusion protein retained the pentameric structure characteristic
of bacterial CTB and conserved the antigenic sites for specific
binding to the pentasaccharide GM1-ganglioside receptors
on the intestinal epithelial cells. No signal was detected
when the plate was coated with bovine serum albumin (BSA)
instead of GM1-ganglioside (Figure 3). Daniell et al. (2001a)
expressed CTB, without any coupled foreign peptide, in
tobacco chloroplast and also observed a specific affinity for
GM1-ganglioside. The expression of chimera CTB proteins,
including foreign sequences, was also performed by nuclear
transformation of potato. Fusion proteins were constructed
by linking insulin or a 22-amino acid long epitope from the
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141–153

Figure 3 CTB-GM1-ganglioside binding enzyme-linked immunosorbent
assay. Plates, coated with bovine serum albumin (BSA) or GM1ganglioside, were incubated with plant total soluble protein from three
independent chloroplast transgenic lines (3, 6, 10) of CTB-2L21,
untransformed plant (WT) or 25 ng of bacterial CTB. The absorbance of
the GM1-ganglioside-CTB antibody complex in each case was measured.
2L21, epitope from the VP2 protein of the canine parvovirus; CTB, cholera
toxin B; GM1-ganglioside, pentasaccharide present in the membrane of
the epidermal cells in the intestine of mammals.

rotavirus enterotoxin non-structural protein to the C-terminus
of the CTB. GM1-ganglioside binding assays demonstrated
that both fusion proteins were assembled into biologically
active pentamers and retained the affinity to GM1-ganglioside
(Arakawa et al., 1998b, 2001; Kim and Langridge, 2003).
Therefore, CTB is a good candidate for C-terminal fusion of
foreign sequences in the chloroplast.

Enzyme-linked immunosorbent assay (ELISA)
quantification of the 2L21 epitope
Large differences in the accumulation of recombinant
proteins were observed between plants transformed with
the three different constructs. Three lines transformed with the
pLD-2L21 vector were analysed and none showed expression
of the 2L21 peptide in the ELISA, despite using a dilution
of 1 : 5 (detection limit of 2L21, 6 ng). However, plants
transformed with pLD-CTB-2L21 or pLD-GFP-2L21 plasmids expressed the respective fusion protein at high levels (Figure 4a).
To study the expression level of the recombinant protein
during the life cycle of the plant, we analysed samples of chloroplast transgenic plants grown in a phytotron from transplanting to senescence. In general, the expression of CTB-2L21
was higher than that of GFP-2L21 (Figure 4a,b). The expression of the fusion proteins depended on plant age. Small
plants, 30 cm tall (24 days after transplanting), synthesized
only 0.84 mg/g fresh weight (FW) of CTB-2L21 or 0.37 mg/g
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FW of GFP-2L21 (Figure 4a). There was an arrest or even a
decrease in the synthesis 48 days after transplanting, coinciding with the start of flowering. The maximum levels of recombinant protein (7.49 mg/g FW of CTB-2L21, equivalent to
31.1% TSP; 5.96 mg/g FW of GFP-2L21, equivalent to 22.6%
TSP) were reached after 60 days, matching with full flowering and the appearance of the first green fruits. There was
a decrease in the levels of recombinant proteins when
mature fruits appeared, 69 days after transplanting. The large
amounts of recombinant proteins were confirmed when total

proteins from chloroplast transgenic plants were separated
by sodium dodecylsulphate (SDS)-PAGE and stained with
Coomassie brilliant blue. Predominant bands of the expected
size were observed for CTB-2L21 and GFP-2L21 (Figure 4c).
High levels of CTB-2L21 or GFP-2L21 did not affect the
phenotype of transgenic plants. Transformed and wild-type
control plants grown in the phytotron were indistinguishable.
The high expression levels of these chimera proteins could
be due to a very efficient translation conducted by the psbA
5′-UTR (Eibl et al., 1999). Recently, Fernández-San Millán
et al. (2003) observed that the presence of the psbA 5′-UTR
enhanced the translation and favoured the accumulation of
human serum albumin in tobacco chloroplasts. Daniell et al.
(2001a) expressed the CTB subunit in transgenic chloroplasts
with a maximum accumulation of 4.1% of TSP. This result
contrasts with the high expression level obtained for the
fusion protein CTB-2L21 (31.1% of TSP). In addition to the
difference in the amino acid sequence itself, the CTB gene
was driven by the promoter of the rRNA operon (Prrn), including a ribosome binding site (GGAGG), whereas the CTB-2L21
gene was driven by the promoter and 5′-UTR of the psbA
gene. By using mutants generated by sequence deletion and
base alteration, Zou et al. (2003) have recently demonstrated
that the correct primary sequence and secondary structure of
the psbA 5′-UTR stem-loop are required for mRNA stabilization and translation. Both the different promoter used and
the inclusion of the translation enhancer 5′-UTR sequence
could therefore explain the higher protein levels found in
this work.
To find out whether the leaf age affected the actual level
of recombinant proteins, samples from chloroplast transgenic plants were grown in a phytotron for 65 days and analysed. Young leaves showed the highest levels of GFP-2L21 or

Figure 4 Analysis of recombinant protein accumulation in transgenic
chloroplasts of GFP-2L21 and CTB-2L21 plants. (a) Enzyme-linked
immunosorbent assay of recombinant protein accumulation in plants at
different developmental stages. Total soluble protein was extracted from
young leaves of potted plants in the phytotron. The data are presented
as the means ± SE of measurements on five individual plants per
construction. (b) Recombinant protein accumulation in young, mature
and old leaves of plants growing in the phytotron, 65 days after
transplanting. Data are presented as the means ± SE of measurements on
seven individual plants per construction. (c) Coomassie blue-stained
sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
gel of plant samples, 60 days after transplanting, equivalent to those
shown in (a). Two independent lines (1, 2) for each construction were
analysed. Recombinant proteins GFP-2L21 and CTB-2L21 are marked.
Fifty micrograms of plant total protein were loaded per well. 2L21,
epitope from the VP2 protein of the canine parvovirus; CTB, cholera toxin
B; GFP, green fluorescent protein; MW, molecular weight marker; WT,
wild-type Petit Havana plant.
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141– 153
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Table 1 Yield of the CTB-2L21 recombinant protein expressed in tobacco chloroplast relative to leaf age
Average number of

Fresh weight/leaf

Average amount of

Recombinant protein percentage in

Leaf age

leaves per plant

(g)

CTB-2L21 (mg)

relation to whole plant

Young

3.2

2.5

51

16.5

Mature

7.8

8.0

235

75.8

Old

2.6

5.0

24

7.7

Total recombinant protein (mg) per plant

310

100

Young, small dark-green leaves from the upper part of the plant; mature, large, well-developed leaves from the middle of the plant; old, bleached leaves or those
undergoing senescence from the bottom of the plant; CTB-2L21, cholera toxin B protein including 2L21 epitope from the VP2 protein of the canine parvovirus.

CTB-2L21 (Figure 4b). Old senescent leaves showed much
lower amounts of recombinant protein in both types of plant,
4-fold (CTB-2L21) or 18-fold (GFP-2L21) lower than that
in young leaves (Figure 4b). Usually, the content of TSP also
decreased from young to old leaves, and the profiles of
recombinant proteins matched those of TSP. Thus, the
amount of recombinant protein expressed as the percentage
of TSP remained basically unchanged (Stevens et al., 2000)
despite the fact that old leaves accumulated very low
amounts of recombinant protein in comparison with mature
and young leaves.
In order to quantify the yield of recombinant protein per
plant and the relative contributions of young, mature and old
leaves, CTB-2L21 protein levels were estimated according to
the number and weight of leaves per plant (Table 1). A total
of 310 mg of CTB-2L21 could be produced per plant, 75.8%
of this coming from mature leaves and 16.5% from young
leaves. Only 7.7% was produced in old leaves. We believe
that the expression of recombinant protein levels as mg/g
FW is more reliable than as a percentage of TSP, as TSP values
may be highly variable depending on the physiological and
environmental conditions (Stevens et al., 2000). This fact and
the recombinant protein content according to the age of
the plant must be taken into consideration when scaling up
the processes.
Why did the plants transformed with the pLD-2L21 vector
not accumulate the 2L21 peptide? Analysis at the transcriptional level in the three different types of chloroplast transgenic plants revealed transcripts of the expected size in all of
them (Figure 5). This precludes deficient transcription or
mRNA stability. Our hypothesis is that the messenger may be
correctly translated, but the 22-amino acid long peptide is
recognized as a foreign molecule in the stroma of the chloroplast and is rapidly degraded. In bacteria, with an equivalent transcriptional and translational machinery to that of the
chloroplast, the expression of peptides shorter than 60 amino
acids is often ineffective because of degradation (Dobeli et al.,
1998). Thus peptides are generally expressed in bacteria as
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141–153

Figure 5 Northern blot analysis of chloroplast transgenic plants. Total
RNA was extracted from leaves of potted plants in the phytotron. Two
independent lines (1, 2) for each construction (2L21, GFP-2L21,
CTB-2L21) were analysed. The 108 bp 2L21 sequence was used as a
probe. Ten micrograms of total RNA were loaded per well. Ethidium
bromide-stained rRNA was used to assess loading. 2L21, epitope from the
VP2 protein of the canine parvovirus; CTB, cholera toxin B; GFP, green
fluorescent protein; rRNA, ribosomal RNA; WT, wild-type Petit Havana
plant.

fusion proteins. Many proteins located in the stroma of the
chloroplast or in the lumen of the thylakoids are synthesized
in the nucleus and require a single or double transit peptide.
These transit peptides, cleaved by specialized endopeptidases, do not accumulate in chloroplasts, suggesting that
they are probably further degraded by proteases (Adam,
2000). Small polypeptides are usually unstable in the stroma
of the chloroplast. Leelavathi and Reddy (2003) showed that
interferon gamma had a short half-life in transgenic chloroplasts, but this could be extended by GUS fusion. A similar
pattern was observed with the fusion between ubiquitin
and human somatotropin (Staub et al., 2000). Therefore, the
2L21 peptide might be expressed but may be degraded at a
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faster rate. DeGray et al. (2001) expressed an antimicrobial
peptide in transgenic chloroplasts, showing the plant extract’s
antibacterial activity. Although both peptides are composed
of 22 amino acids, their sequences are different and may be
degraded accordingly by sequence-specific peptidases and
proteases (Adam, 2000). A primary structure more sensitive
to chloroplast peptidases could explain the instability of the
2L21 peptide in the stroma of the chloroplast.

Antibody response to plant-derived 2L21 immunogens
In order to study the immunogenicity of plant-derived 2L21
constructions, Balb/c mice were immunized intraperitoneally
(i.p.) with leaf extracts from CTB-2L21-, GFP-2L21- and 2L21transformed plants or non-transformed plants (control) as
described in ‘Experimental procedures’. All mice immunized
with CTB-2L21 elicited anti-2L21 antibodies (titres ranged
from 200 to 25 000) (Figure 6). None of the sera from groups
immunized with leaf extracts from 2L21-transformed plants
and non-transformed plants recognized 2L21 peptide (titre,
< 10) and only one of six mice from the GFP-2L21 group
showed a marginal response against 2L21 peptide (titre,
20) (data not shown). To determine whether the humoral
response elicited recognized viral native protein, sera were

Figure 6 Titres of antibodies at day 50 induced by plant-derived CTB2L21 recombinant protein. Balb/c mice were intraperitoneally immunized
with leaf extract from CTB-2L21 transgenic plants. Animals were boosted
at days 21 and 35. Each mouse received 20 µg of CTB-2L21 recombinant
protein. Individual mice sera were titrated against 2L21 synthetic peptide,
VP2 protein and control peptide (amino acids 122–135 of hepatitis B virus
surface antigen). Titres were expressed as the highest serum dilution to
yield twice the absorbance mean of pre-immune sera. M1–M6, mouse 1–
6; 2L21, epitope from the VP2 protein of the canine parvovirus; CTB,
cholera toxin B; VP2, protein of the canine parvovirus that includes the
2L21 epitope.

titrated against VP2 protein. Only mice immunized with
leaf extracts containing CTB-2L21 recognized VP2 in ELISA
(Figure 6). No antibody titres (titre, < 10) were found against
the control peptide (Figure 6).
These results show that plant-derived CTB-2L21 recombinant protein is immunogenic by the i.p. route, being able
to induce a humoral response that cross-reacts with native
VP2 protein. CTB protein is a well-known carrier protein able
to potentiate the immune response against fused peptides
(McKenzie and Halsey, 1984). This immunological property
would explain the anti-2L21 response detected in the
CTB-2L21 group. The conserved pentameric conformation
(Figure 2b,c) and GM1-ganglioside binding property (Figure 3)
of CTB-2L21 chimera protein augur that this C-terminal CTB
fusion protein must also be a good immunogen for mucosal
delivery. The fact that no antibody immune response was
elicited with extracts from GFP-2L21-transformed plants suggests that GFP protein does not act as an efficient immunological carrier. The lack of humoral response in the 2L21
group could be explained by the poor immunogenicity of
the 2L21 peptide and the instability of short peptides in plant
cells. Previous reports have shown that free 2L21 peptide is a
poor immunogen that requires coupling to KLH protein to
induce antibodies (Langeveld et al., 1994a,b).
Oral vaccination is able to induce both mucosal and systemic immune response. Indeed, a mucosal immune response
is more effectively achieved by oral, rather than parenteral,
antigen delivery. Therefore, oral vaccination is of special
interest because many infectious agents colonize or invade
epithelial membranes. One of the major advantages of the
high expression of recombinant proteins in chloroplast transgenic plants is the low dose required for oral vaccination.
Clinical trials in phase I have been reported for the Norwalk
virus (Tacket et al., 2000), bacterial diarrhoea (Tacket et al.,
1998) and hepatitis B virus (Kapusta et al., 2001). Volunteers
ingested raw material from potato tubers or lettuce leaves
(ranging from 50 to 200 g per dose, equivalent to 0.3–
750 µg of antigen). Most of the individuals developed IgGand IgA-specific antibodies against the plant-derived antigen,
although some subjects who ate these large amounts of raw
potato tubers showed side-effects, such as vomiting, diarrhoea and fever (Tacket et al., 2000). A standard oral delivery
vaccination programme consisting of three doses is not practical if a large amount of plant material must be eaten per
dose. By using chloroplast transgenic plants with expression
levels equivalent to those reported in this paper, very small
amounts of plant material would be required per dose
(80–100 mg for a quantity of 500 µg recombinant protein),
allowing the encapsulation of freeze-dried material or pill
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formation. Nevertheless, it must be demonstrated case-bycase that dried leaf material can induce immune responses
when ingested, and that the antigen integrity can be maintained for long periods at room temperature. In the present
work, we chose tobacco as the host plant because the chloroplast transformation method is very efficient. However, the
presence of toxic alkaloids in the tobacco plant make this
system incompatible with oral delivery in humans (Mason et al.,
2002). Thus, a great effort must be made to transfer the
plastid transformation strategy to less toxic and more palatable
species, such as spinach, lettuce or cereal species that do not
need to be cooked, e.g. maize meal.
In conclusion, we have expressed the fusion proteins CTB2L21 and GFP-2L21 at very high levels in tobacco chloroplasts. This will facilitate the use of raw plant material for
the delivery of an oral vaccine against CPV. Recognition of the
2L21-inserted epitope by the anti-2L21 mAb 3C9 in Western
blot (Figure 2) and ELISA (Figure 4) indicates that this epitope
is correctly presented at the C-terminus of CTB and GFP proteins. Recognition of CTB-2L21 protein by CPV-neutralizing
mAb 3C9 (Lopez de Turiso et al., 1991) and induction of an
anti-VP2 cross-reactive immune response after i.p. injection
of plant-derived CTB-2L21 protein suggest that this chimera
protein might be able to induce a protective immune response
against CPV. Additional experiments are underway to check
the ability of this fusion protein to develop specific immune
responses after mucosal delivery. So far, mainly human or
bacterial proteins have been expressed in chloroplast transgenic plants (Daniell et al., 2002). To our knowledge, this is
the first time an animal vaccine epitope has been expressed
in transgenic chloroplasts.

Experimental procedures
Construction of the chloroplast expression vectors
The tobacco chloroplast expression vector pLD-BADH was
constructed by inserting the BADH 1.5 kb SmaI fragment
into the EcoRV site of the pLD vector (Daniell et al., 1998,
2001a,b; Kota et al., 1999; Guda et al., 2000), including the
new sites SacII, MluI, Sal I, DraII, Kpn I and EcoRI in its 3′ end.
This fragment contains the BADH coding sequence preceded
by a Shine-Dalgarno (GGAGG) and has an ATG as the initiation codon. These sequences were introduced by using
the primers 5′-CACCCCGGGGGAGGCAACCATGGCGTTCCCAATTCC-3′ and 5′-CACCCCGGGGAATTCGGTACCAGGCCCCGTCGACACGC GTCCGCGGTCAAGGAGACTTGTACC3′, and amplified by PCR using the pLD-St-BADH vector as
template.
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141–153

The DNA sequence corresponding to the parvovirus 2L21
epitope was obtained by a PCR-based gene assembly by
using the following overlapping primers: 5′-GGGACATGTCTGACGGTGCTGTACAACCTGACGGTGGTCAACCTGCTGTA-3′
and
5′-GGGGCGGCCGCTTAACCAGTAGCACGTTCGTTACGTACAGCAGGTTGACCACCGTC-3′ (italic overlapping
sequences). The codon usage was referred to the chloroplast
psbA gene. The PCR product was cloned into the pGEM-T
plasmid (Promega). The AflIII/NotI pGEM-T fragment was
fused to the promoter and 5′-UTR of the psbA gene, giving
the p2L21 vector. The KpnI/NotI fragment from p2L21,
including the promoter and 5′-UTR of the psbA gene, and the
2L21 sequence, was inserted into the pLD-BADH vector,
giving the pLD-2L21 vector.
For the fusion proteins CTB-2L21 and GFP-2L21, the
flexible hinge tetrapeptide GPGP (Arakawa et al., 1998b) was
fused by PCR to the 5′ end of the 2L21 sequence by using the
primers 5′-CCCGGGCCCATGTCTGACGGTGCTG-3′ and
5′-GGGGCGGCCGCT TAACCAGTAGCACGT TCGT TACGTACAGCAGGTTGACCACCGTC-3′. The 75 bp SmaI/NotI
fragment of the 2L21, including the hinge tetrapeptide, was
inserted at the 3′ end of the CTB gene. The CTB gene included
the promoter and 5′-UTR of the psbA gene. Finally, the SalI/
NotI fusion sequence was inserted into the pLD-BADH vector,
giving the pLD-CTB-2L21 vector.
The GFP gene was amplified by PCR using the primers 5′GGGTCATGAGTAAAGGAGAAG-3′ and 5′-GCGGCCGCTCCCGGGCCCTTTGTATAGTTCATCCATG-3′ and, as template,
the soluble modified version of the GFP gene (GENBANK accession no. U70495, obtained under no. CD3-326 from the
Arabidopsis Biological Resource Center, The Ohio State University).
The 75 bp SmaI /NotI fragment of the 2L21, including the
hinge tetrapeptide, was inserted at the 3′ end of the GFP
gene. The 775 bp BspHI/NotI GFP-2L21 fragment was fused
to the promoter and 5′-UTR of the psbA gene. Finally, the
SalI /NotI fusion sequence was inserted into the pLD-BADH,
giving the pLD-GFP-2L21 vector.

Bombardment and regeneration of chloroplast
transgenic plants
Gold microprojectiles coated with plasmid DNA (pLD-2L21,
pLD-CTB-2L21 or pLD-GFP-2L21) were bombarded into
tobacco (Nicotiana tabacum var. Petit Havana) in vitro-grown
leaves using the biolistic device PDS1000/He (Bio-Rad)
as described previously (Daniell, 1997; DeGray et al., 2001).
After bombardment, leaves were incubated in the dark
for 2 days at 28 °C. Leaves were then cut into small pieces
(∼5 mm × 5 mm) and placed abaxial side up on selection medium
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(RMOP) (Daniell, 1993) in Magenta vessels (Sigma) containing 500 mg/ L spectinomycin dihydrochloride as selecting
agent. The growth conditions of the culture chamber were
28 °C, 120 µmol/m2/s and 16 h photoperiod. Resistant
shoots obtained after 6 –7 weeks were cut into small pieces
(∼2 mm × 2 mm) and subjected to a second round of selection in the same selection medium. Regenerated plants were
transplanted and grown in a phytotron with the following
conditions: 28 °C, 250 µmol/m2/s, 70% relative humidity and
16 h photoperiod.

Southern and Northern blot analysis
Total plant DNA (10 µg) was digested with EcoRI, separated
on a 0.8% (w/v) agarose gel and transferred to a nylon membrane. The chloroplast vector DNA digested with BglII and
BamHI generated a 0.8 kb probe (P1) homologous to the
flanking sequences. Hybridization was performed using the
chemiluminescent AlkPhos direct labelling-detection system
(Amersham). After Southern blot confirmation, plants were
transferred to soil. Seeds from the T0 generation were in vitro
germinated on spectinomycin selection medium. The T1 seedlings were isolated and cultured for 2 weeks in Magenta
vessels. Finally, plants were transferred to pots. Plants of T0
and T1 generations were analysed for homoplasmy.
Total RNA was extracted from leaf tissue as described
by Logemann et al. (1987). RNA (10 µg) was separated on
2% agarose/formaldehyde gels and then transferred to a
nylon membrane. The pGEM-T-2L21 vector DNA digested
with EcoRI generated a 108 bp probe (P2) homologous to
the 2L21 sequence. Hybridization was performed using the
chemiluminescent detection system mentioned above.

Western blot analysis
Transformed and untransformed leaves (100 mg) from plants
grown in a phytotron were ground in liquid nitrogen and
resuspended in 200 µL of protein extraction buffer (15 mM
Na2CO3, 35 mM NaHCO3, pH 9.6). Leaf extracts (5–10 µg as
determined by Bradford assay), unboiled or boiled for 5 min
with β-mercaptoethanol, were electrophoresed in a 13%
polyacrylamide gel. Separated proteins were transferred to
a nitrocellulose membrane for immunoblotting. VP2 protein
from CPV (Ingenasa, Madrid, Spain) and CTB protein (Sigma,
C9903) were used as positive controls. The primary antibody
to detect the 2L21 epitope (mouse anti-VP2 mAb 3C9;
Ingenasa, Madrid, Spain) was used at 0.5 µg/mL, and the
secondary antibody (peroxidase-conjugated rabbit anti-mouse
IgG, Sigma A9044) was used at 1 : 30 000 dilution. The

primary antibody to detect CTB (rabbit anti-CTB, Sigma
C3062) was used at 1 : 5000 dilution, and the secondary
antibody (peroxidase-conjugated goat anti-rabbit IgG, Sigma
A9169) was used at 1 : 10 000. Detection was performed
using the ECL Western blotting system (Amersham).

GM1-ganglioside binding assay
Microtitre plates (Costar Corning) were coated with GM1-ganglioside (Sigma G7641) by incubating the plate (overnight at
4 °C) with a solution of GM1-ganglioside (3.0 µg /mL) in bicarbonate buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6).
Alternatively, some wells were coated with BSA as controls.
Wells were blocked with 1% BSA in phosphate-buffered
saline pH 7.4 (PBS), washed three times with PBS containing
0.1% Tween-20 (PBS-T) and incubated (overnight at 4 °C)
with soluble protein from pLD-CTB-2L21-transformed plants,
untransformed controls or bacterial CTB as positive control.
Later, plates were incubated (2 h at 37 °C) with a 1 : 8000
dilution in 0.5% BSA of rabbit anti-CTB antibody (Sigma
C3062) (100 µL /well), washed three times with PBS-T and
then incubated (2 h at 37 °C) with a 1 : 50 000 dilution in
0.5% BSA of peroxidase-conjugated goat anti-rabbit IgG
(Sigma A9169) (100 µL /well). The plate was incubated for 2 h
at 37 °C and washed three times with PBS-T. After washing,
the plates were finally incubated with ABTS (Roche 102 946)
for 1 h at room temperature (RT) in the dark and read at
405 nm in a Multiskan microtitre reader plate (Labsystems).

ELISA quantification of recombinant proteins
Transformed and untransformed leaves (100 mg) from plants
grown in a phytotron were ground in liquid nitrogen and
resuspended in 500 µL of bicarbonate buffer (15 mM Na2CO3,
35 mM NaHCO3, pH 9.6). Samples were bound to a 96-well
polyvinyl chloride microtitre plate (Costar Corning) overnight
at 4 °C. Background was blocked with 1% (w/v) skimmed
milk in PBS-T (PBS-TM) for 1 h at RT, washed three times with
PBS-T and incubated with anti-VP2 mAb 3C9 (Ingenasa,
Madrid, Spain) at 0.5 µg/mL in PBS-TM (1 h at RT). The wells
were washed three times with PBS-T and incubated with
1 : 50 000 dilution of rabbit anti-mouse IgG-peroxidase
conjugate in PBS-TM (1 h at RT). Plates were developed with
ABTS (Roche 102 946). The reaction was stopped after 1 h
with 1% SDS and read at 405 nm in a Multiskan microtitre
reader plate (Labsystems). A standard curve to calculate the
amount of recombinant protein was made by plating a synthetic 2L21 peptide (Bioworld, Ohio, USA) in the range 6–
56 ng per well in 100 mM Na2CO3 pH 10.5. Transgenic leaf
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2004), 2, 141– 153
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extracts were diluted to fit in the linear range of the 2L21
standard.

Immunogenicity measurements
Female Balb/c mice (Harlan Ibérica, Barcelona, Spain) were
used in this experiment. Groups of 4-week-old mice (n = 6)
were immunized by i.p. injection (0.2 mL) with crude leaf
extract from CTB-2L21-, GFP-2L21- and 2L21-transformed
plants in Complete Freund’s Adjuvant (CFA). CTB-2L21 and
GFP-2L21 groups received 20 µg /mouse of 2L21 recombinant protein. The amount of TSP varied between 140 and
200 µg. The 2L21 group received 200 µg of TSP/mouse. As
a control, a group of mice (n = 6) was immunized i.p. with
leaf extracts from non-transformed plants (200 µg /mouse of
TSP). Animals were boosted at days 21 and 35, using Incomplete Freund’s Adjuvant (IFA) instead of CFA. Blood was
collected from the retro-orbital plexus at days 0 and 50.
Individual mice sera were titrated against 2L21 synthetic
peptide (1 µg/ well), VP2 protein (0.1 µg /well) and control peptide WNSTAFHQTLQDPR (amino acids 122–135 of hepatitis
B virus surface antigen) (Bioworld, Ohio, USA) (1 µg / well) by
an in-house ELISA described in Hervas-Stubbs et al. (1994).
Titres were expressed as the highest serum dilution to yield
twice the absorbance mean of pre-immune sera.
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